Acer Therapeutics Inc. (ACER) Social Stream
Acer Therapeutics Inc (ACER) Price Targets From Analysts
Use the tables below to see what analysts covering Acer Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ACER's average price target has moved up $3.83 over the prior 22 months.
Over the past 48 weeks, ACER's average upside potential has been 292.5%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ACER Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
ACER's average broker recommendation rating improved by 1.67 over the prior 26 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ACER has a greater number of analysts covering the stock than 9.42% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Acer Therapeutics Inc's variance in analysts' estimates is lower than 86.8% of them.
- In the context of Healthcare stocks, Acer Therapeutics Inc's average analyst price target is higher than 48.71% of them.
- Acer Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 228.73% of stocks in the small market cap category.
In the Pharmaceutical Products industry, ABUS, ABEO, and VIGL are the three stocks most similar to Acer Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Is ACER a Buy, Hold or Sell? See the POWR Ratings now!